Skip to main content
. 2023 Apr 10;25(10):3021–3031. doi: 10.1007/s12094-023-03171-z

Table 2.

Characteristics of VTE/AT episodes in patients with kidney cancer

Parameter Subparameter n = 12
Type VTE/ AT PE 33.3% (n = 4)
DVT 8.3% (n = 1)
Other forms of VTE: visceral, associated with catheter… 33.3% (n = 4)
Cerebral stroke 8.3% (n = 1)
Acute myocardial infarction 8.3% (n = 1)
Other forms of AT 8.3% (n = 1)
Tumor reevaluation at diagnosis of VTE/AT Complete response 0% (n = 0)
Partial response 0% (n = 0)
Stable disease 41.7% (n = 5)
Unconfirmed progression 8.3% (n = 1)
Confirmed progression 41.7% (n = 5)
Not reevaluated 8.3% (n = 1)
VTE/AT presentation Incidental 41.7% (n = 5)
Symptomatic 58.3% (n = 7)
Setting of VTE/AT diagnosis Outpatient 83.3% (n = 10)
In-patient 16.7% (n = 2)
Setting of VTE/AT management Outpatient 50% (n = 6)
In-patient 50% (n = 6)

AT arterial thrombosis, DVT deep vein thrombosis, PE pulmonary embolism, VTE venous thromboembolism